Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02268370
Title Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

chronic myeloid leukemia

Therapies

Dasatinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.